Artivion Inc (AORT) Stock Price, Quote & News

Company Profile

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic...

Industry: Medical Devices

Sector: Healthcare

Phone: 770 419 3355

Website: artivion.com

Address:

1655 Roberts Boulevard NW, Kennesaw, United States

Primeoptionsst Aug. 11 at 6:58 PM

LOADING UP!! 📊 $AORT 21 AUG 26 $30 CALL $0.35 GAP FILL IN PLAY + FRESH PRICE UPGRADE THIS SETUP IS GETTING INTERESTING!!

0 · Reply

Primeoptionsst Aug. 11 at 6:57 PM

$AORT 21 AUG 26 $30 CALL $0.35 🚨 GAP-FILL SETUP + PRICE UPGRADE 🚨 EARLY ENTRY. STRONG SETUP. 📉

0 · Reply

Alphatrades09 Aug. 11 at 6:51 PM

$AORT below my fill swinging full don’t miss it🔥

0 · Reply

Equityforge01 Aug. 11 at 6:50 PM

$AORT 21 AUG 26 $30 CALL $0.35

0 · Reply

MC_Official Aug. 11 at 6:49 PM

🚨 OPENED: $AORT 08/21/26 💰 Entry: $0.35

0 · Reply

Blockwave01 Aug. 11 at 6:48 PM

$AORT 21 AUG 26 $30 CALL $0.35 GAP FILL PLAY + PRICE UPGRADE

0 · Reply

Noxtradealerts Aug. 11 at 6:48 PM

$AORT 21 AUG 26 $30 CALL $0.35

0 · Reply

Alphatrades09 Aug. 11 at 6:47 PM

$AORT 30C 8/21 @ 0.35 🔥

0 · Reply

LUXtrades0 Aug. 11 at 6:47 PM

$AORT 21 AUG 26 $30 CALL $0.35 🤾🏼‍♂️

0 · Reply

StocktwitsEarnings Aug. 6 at 8:16 PM

$AORT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.28 down -1033.33% YoY • Reported revenue of $125.76M up 11.32% YoY • Artivion reiterates its full year 2026 revenue expectations in the range of $480 to $496 million, with adjusted EBITDA forecasted to be in the range of $92 to $99 million.

0 · Reply

Artivion Transcript: Canaccord Genuity's 46th Annual Growth Conference

2026-08-07T13:16:53.000Z - 5 days ago

Artivion price target lowered to $39.20 from $42 at Ladenburg

2026-08-07T11:21:42.000Z - 6 days ago

Artivion price target raised to $39 from $36 at Canaccord

2026-08-06T20:47:23.000Z - 6 days ago

Artivion reports Q2 non-GAAP EPS 13c, consensus 10c

2026-08-06T20:46:56.000Z - 6 days ago

Artivion repeats 2026 revenue $480M-$496M, consensus $486.23M

Aug 6, 2026, 4:30 PM EDT - 6 days ago

Artivion Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 days ago

Artivion Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 days ago

Artivion Slides: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 days ago

Artivion Quarterly report: Q2 2026

Aug 6, 2026, 4:05 PM EDT - 6 days ago

Artivion Reports Second Quarter 2026 Financial Results

Aug 1, 2026, 8:00 AM EDT - 12 days ago

Artivion Slides: Investor presentation

Jul 28, 2026, 4:10 PM EDT - 15 days ago

Artivion to Participate in Upcoming Investor Conferences

Jul 23, 2026, 4:10 PM EDT - 20 days ago

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results

Jul 23, 2026, 10:00 AM EDT - 20 days ago

GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs

AMYY AZYY BBYY BIOY COYY CRY CWY

2026-06-29T11:15:59.000Z - 6 weeks ago

Artivion announces U.S. FDA approval of AMDS Hybrid Prosthesis

Jun 29, 2026, 7:00 AM EDT - 6 weeks ago

Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

Jun 16, 2026, 1:00 PM EDT - 2 months ago

Artivion Transcript: Truist Securities MedTech Conference 2026

Jun 10, 2026, 4:10 PM EDT - 2 months ago

Artivion to Participate in the 2026 Truist Securities MedTech Conference

Jun 4, 2026, 8:50 AM EDT - 2 months ago

GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs.

AMYY AZYY BBYY BIOY COYY CRY CWY

May 21, 2026, 8:18 AM EDT - 3 months ago

GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, AMYY, TQQY, AZYY, YSPY, MTYY, PLYY, HOYY, SMYY, BBYY, FBYY, IOYY, MAAY, NUGY, SEMY, QBY, RGYY, HMYY, RTYY, MUYY, TMYY, CWY, CRY and 20+ Others

AMYY AZYY BBYY COYY CRY FBYY HMYY

2026-05-18T11:18:12.000Z - 3 months ago

Endospan announces Artivion closed the transaction to acquire the company

May 18, 2026, 7:05 AM EDT - 3 months ago

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

May 18, 2026, 7:00 AM EDT - 3 months ago

Artivion Completes Acquisition of Endospan Ltd.

2026-05-11T15:09:55.000Z - 3 months ago

3 Small-Cap Stocks with ‘Strong Buy’ Ratings and Big Upside in 2026

DSP REAL

2026-05-08T22:36:17.000Z - 3 months ago

Artivion price target lowered to $44 from $58 at Needham

2026-05-08T16:22:10.000Z - 3 months ago

Artivion price target lowered to $45 from $55 at Lake Street

2026-05-08T15:46:07.000Z - 3 months ago

Artivion price target lowered to $38 from $50 at Oppenheimer

2026-05-08T13:11:24.000Z - 3 months ago

Artivion price target lowered to $45 from $55 at Stifel

2026-05-08T11:41:40.000Z - 3 months ago

Artivion price target lowered to $36 from $48 at Canaccord

2026-05-08T09:56:27.000Z - 3 months ago

Artivion price target lowered to $48 from $53 at Citizens

2026-05-07T23:01:21.000Z - 3 months ago

Artivion reports Q1 non-GAAP EPS 8c, consensus 12c

2026-05-07T22:58:32.000Z - 3 months ago

Artivion lowers 2026 revenue view to $480M-$496M from $486M-$504M

May 7, 2026, 4:30 PM EDT - 3 months ago

Artivion Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Artivion Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Artivion Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Artivion Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 3 months ago

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

May 7, 2026, 7:00 AM EDT - 3 months ago

Artivion Slides: Corporate presentation

Apr 28, 2026, 8:00 AM EDT - 3 months ago

GraniteShares Expands YieldBOOST(TM) Lineup with Launch of CRY and XEY ETFs

CRY XEY

Apr 23, 2026, 4:15 PM EDT - 3 months ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

2026-04-20T10:38:49.000Z - 4 months ago

Artivion added to Conviction List at Needham

2026-04-10T10:46:30.000Z - 4 months ago

Artivion upgraded to Buy from Neutral at Ladenburg

2026-04-07T11:27:48.000Z - 4 months ago

Artivion’s PMA for Nexus Aortic Arch System approved by the FDA

Apr 7, 2026, 7:00 AM EDT - 4 months ago

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

Apr 1, 2026, 8:00 AM EDT - 4 months ago

Artivion Proxy statement: Proxy filing

Apr 1, 2026, 8:00 AM EDT - 4 months ago

Artivion Proxy statement: Proxy filing

Mar 17, 2026, 9:20 AM EDT - 5 months ago

Artivion Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 3, 2026, 4:10 PM EST - 5 months ago

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

2026-02-13T11:52:06.000Z - 6 months ago

Artivion price target lowered to $48 from $51 at Canaccord

Feb 12, 2026, 4:30 PM EST - 6 months ago

Artivion Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

Artivion Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

Artivion Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

Artivion Slides: Q4 2025

2026-02-12T21:11:58.000Z - 6 months ago

Artivion reports Q4 non-GAAP EPS 17c, consensus 18c

Feb 12, 2026, 4:05 PM EST - 6 months ago

Artivion Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 2, 2026, 8:00 AM EST - 6 months ago

Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting

Jan 29, 2026, 4:05 PM EST - 6 months ago

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results

Nov 12, 2025, 8:00 AM EST - 9 months ago

Artivion Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 7:00 AM EST - 9 months ago

Artivion Slides: Corporate Presentation

Nov 6, 2025, 4:30 PM EST - 9 months ago

Artivion Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Artivion Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Artivion Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Artivion Slides: Q3 2025

Nov 6, 2025, 4:05 PM EST - 9 months ago

Artivion Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 8:00 AM EST - 10 months ago

Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial

Oct 29, 2025, 4:10 PM EDT - 10 months ago

Artivion to Participate in the Stifel 2025 Healthcare Conference

Oct 23, 2025, 4:10 PM EDT - 10 months ago

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results

Oct 13, 2025, 8:00 AM EDT - 10 months ago

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Sep 10, 2025, 2:35 PM EDT - 1 year ago

Artivion Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 5, 2025, 4:10 PM EDT - 1 year ago

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 13, 2025, 10:30 AM EDT - 1 year ago

Artivion Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Artivion Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Artivion Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Artivion Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Artivion Slides: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 1 year ago

Artivion Reports Second Quarter 2025 Financial Results

Jul 24, 2025, 4:10 PM EDT - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results

Jun 17, 2025, 8:00 AM EDT - 1 year ago

Artivion Transcript: 2025 Truist Securities MedTech Conference

May 28, 2025, 5:51 PM EDT - 1 year ago

Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 28, 2025, 7:00 AM EDT - 1 year ago

Artivion Slides: Investor Presentation

May 14, 2025, 4:01 PM EDT - 1 year ago

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 5, 2025, 4:30 PM EDT - 1 year ago

Artivion Earnings Call Transcript: Q1 2025

May 5, 2025, 4:30 PM EDT - 1 year ago

Artivion Quarterly report: Q1 2025

May 5, 2025, 4:30 PM EDT - 1 year ago

Artivion Earnings release: Q1 2025

May 5, 2025, 4:30 PM EDT - 1 year ago

Artivion Slides: Q1 2025

May 5, 2025, 4:05 PM EDT - 1 year ago

Artivion Reports First Quarter 2025 Financial Results

May 5, 2025, 7:00 AM EDT - 1 year ago

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

Apr 21, 2025, 4:10 PM EDT - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Artivion Proxy statement: Proxy Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Artivion Proxy statement: Proxy Filing

Mar 18, 2025, 10:40 AM EDT - 1 year ago

Artivion Transcript: Oppenheimer 35th Annual Health Care MedTech and Services Conference

Mar 4, 2025, 4:05 PM EST - 1 year ago

Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Feb 24, 2025, 4:30 PM EST - 1 year ago

Artivion Earnings Call Transcript: Q4 2024

Feb 24, 2025, 4:30 PM EST - 1 year ago

Artivion Annual report: Q4 2024

Feb 24, 2025, 4:30 PM EST - 1 year ago

Artivion Earnings release: Q4 2024

Feb 24, 2025, 4:30 PM EST - 1 year ago

Artivion Slides: Q4 2024

Feb 24, 2025, 4:05 PM EST - 1 year ago

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 10, 2025, 4:10 PM EST - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

Jan 27, 2025, 8:00 AM EST - 1 year ago

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

Dec 9, 2024, 10:52 AM EST - 1 year ago

US medical device giant Artivion says hackers stole files during cybersecurity incident

Dec 9, 2024, 8:00 AM EST - 1 year ago

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

Nov 19, 2024, 1:15 PM EST - 1 year ago

Artivion Transcript: Stifel 2024 Healthcare Conference

Nov 7, 2024, 4:30 PM EST - 1 year ago

Artivion Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Artivion Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Artivion Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Artivion Slides: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

Artivion Reports Third Quarter 2024 Financial Results

Oct 24, 2024, 4:15 PM EDT - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

Oct 10, 2024, 4:10 PM EDT - 1 year ago

Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Aug 14, 2024, 2:00 PM EDT - 2 years ago

Artivion Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Artivion Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Artivion Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Artivion Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Artivion Slides: Q2 2024

Aug 8, 2024, 4:05 PM EDT - 2 years ago

Artivion Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 4:10 PM EDT - 2 years ago

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

Jul 1, 2024, 4:05 PM EDT - 2 years ago

Artivion Amends Agreements with Endospan

May 6, 2024, 4:30 PM EDT - 2 years ago

Artivion Earnings Call Transcript: Q1 2024

May 6, 2024, 4:30 PM EDT - 2 years ago

Artivion Quarterly report: Q1 2024

May 6, 2024, 4:30 PM EDT - 2 years ago

Artivion Earnings release: Q1 2024

May 6, 2024, 4:30 PM EDT - 2 years ago

Artivion Slides: Q1 2024

May 6, 2024, 4:05 PM EDT - 2 years ago

Artivion Reports First Quarter 2024 Financial Results

Apr 29, 2024, 8:05 AM EDT - 2 years ago

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

Apr 22, 2024, 4:10 PM EDT - 2 years ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

Apr 8, 2024, 10:15 AM EDT - 2 years ago

Artivion Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 1, 2024, 4:10 PM EDT - 2 years ago

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Artivion Proxy statement: Proxy Filing

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Artivion Proxy statement: Proxy Filing

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Artivion Proxy statement: Proxy Filing

Mar 13, 2024, 10:40 AM EDT - 2 years ago

Artivion Transcript: Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Mar 6, 2024, 4:10 PM EST - 2 years ago

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Primeoptionsst Aug. 11 at 6:58 PM

LOADING UP!! 📊 $AORT 21 AUG 26 $30 CALL $0.35 GAP FILL IN PLAY + FRESH PRICE UPGRADE THIS SETUP IS GETTING INTERESTING!!

0 · Reply

Primeoptionsst Aug. 11 at 6:57 PM

$AORT 21 AUG 26 $30 CALL $0.35 🚨 GAP-FILL SETUP + PRICE UPGRADE 🚨 EARLY ENTRY. STRONG SETUP. 📉

0 · Reply

Alphatrades09 Aug. 11 at 6:51 PM

$AORT below my fill swinging full don’t miss it🔥

0 · Reply

Equityforge01 Aug. 11 at 6:50 PM

$AORT 21 AUG 26 $30 CALL $0.35

0 · Reply

MC_Official Aug. 11 at 6:49 PM

🚨 OPENED: $AORT 08/21/26 💰 Entry: $0.35

0 · Reply

Blockwave01 Aug. 11 at 6:48 PM

$AORT 21 AUG 26 $30 CALL $0.35 GAP FILL PLAY + PRICE UPGRADE

0 · Reply

Noxtradealerts Aug. 11 at 6:48 PM

$AORT 21 AUG 26 $30 CALL $0.35

0 · Reply

Alphatrades09 Aug. 11 at 6:47 PM

$AORT 30C 8/21 @ 0.35 🔥

0 · Reply

LUXtrades0 Aug. 11 at 6:47 PM

$AORT 21 AUG 26 $30 CALL $0.35 🤾🏼‍♂️

0 · Reply

StocktwitsEarnings Aug. 6 at 8:16 PM

0 · Reply

Estimize Aug. 6 at 3:01 PM

$AORT reports after the close, Estimize Consensus +0.01 EPS and +1.11M Revs compared to WS http://www.estimize.com/aort/fq2-2026?utm_conten

0 · Reply

OpenOutcrier Jun. 29 at 12:49 PM

$AORT (+1.2% pre) Artivion receives FDA approval for aortic dissection device https://ooc.bz/l/106461

0 · Reply

TheMACDaddy Jun. 25 at 7:09 PM

$AORT Took a little longer than expected, but out with my 10%. On to the next!

0 · Reply

macroaxis Jun. 20 at 10:42 PM

$AORT Artivion max pain price falls to -1.0 https://www.macroaxis.com/stock-options/AORT/Artivion?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

TheMACDaddy Jun. 4 at 2:22 PM

$AORT RSI = 24 (extremely bullish) Institutional Ownership = 91% MACD = broke positive on short term charts Trending = just hit supporting 5-year chat. Very strong support line News: Acquisition on 18th mostly overlooked Easy buy here, entered at $21.17

0 · Reply

Heinzena81 May. 27 at 6:25 PM

$AORT Down 21% over the last 5 years. What an absolute gargabe stock.

0 · Reply

prismmarketview May. 18 at 6:46 PM

$AORT Between AMDS, NEXUS, and future Arcevo LSA, Artivion is building a full toolbox for complex aortic arch repair across open, hybrid, and endovascular approaches. https://prismmarketview.com/artivion-bets-big-on-aortic-arch-locking-in-endospans-nexus-system/

0 · Reply

prismmarketview May. 18 at 12:44 PM

$AORT Artivion has closed its acquisition of Endospan Ltd., bringing the NEXUS Aortic Arch System in‑house after FDA PMA approval and expanding its advanced aortic portfolio. https://prismmarketview.com/artivion-seals-endospan-deal-bringing-nexus-aortic-arch-system-fully-in-house/

0 · Reply

MarketBeat May. 9 at 11:07 AM

Artivion Q1 Earnings Call Highlights $AORT https://www.marketbeat.com/instant-alerts/artivion-q1-earnings-call-highlights-2026-05-09/

0 · Reply

loveisnotez May. 8 at 6:10 PM

$AORT like I said, $30 EOD

0 · Reply

loveisnotez May. 8 at 4:36 PM

$AORT $30

0 · Reply

coregamma May. 8 at 3:21 PM

$AORT with the 1900% RVOL Breakout this morning. Other big movers in this session include: $HRTG $HUBS $NET $AKAM $TSSI $PSEC $TOST $ANIP $NVAX $CHGG

0 · Reply

Market Cap	1.38B
Revenue (ttm)	441.33M
Net Income (ttm)	9.77M
EPS (ttm)	N/A
PE Ratio	48.72
Forward PE	58.47
Profit Margin	2.21%
Debt to Equity Ratio	0.82

Volume	758,900
Avg Vol	762,676
Day's Range	N/A - N/A
Shares Out	48.76M
Stochastic %K	80%
Beta	1.25
Analysts	Strong Sell
Price Target	$42.02